Clinical Significance of Quantitative Level of Hepatitis B Core Antibody

Q Yuan,H You,N S Xia,J D Jia
DOI: https://doi.org/10.3760/cma.j.issn.1007-3418.2017.12.014
2017-01-01
Abstract:Hepatitis B core antibody (anti-HBc) targets viral core protein and is produced in patients with hepatitis B virus (HBV) infection,and seroconversion occurs in the early stage of infection and often lasts for a lifetime.Qualitative detection of anti-HBc has been used in clinical practice for many years,while the clinical significance of its quantitative level remains unclear.A novel anti-HBc immunoassay based on double-antigen sandwich ELISA has been developed in recent years and lays a foundation for illustrating the change in the quantitative level of anti-HBc (qAnti-HBc) in HBV infection and its clinical significance.Several recent studies have revealed that qAnti-HBc is associated with the degree of hepatitis activity and response to pharmacotherapy and may become an important basis for selecting antiviral drugs,optimizing therapeutic regimen,and predicting treatment outcome.
What problem does this paper attempt to address?